Tumor-targeted Salmonella as a novel anticancer vector

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4537-4544

  Pawelek, John M ^a   Low, K Brooks ^a   Bermudes, David ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Vion Pharmaceuticals Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; EFFECTOR CELL; ENZYME PHOSPHORYLATION; GENE AMPLIFICATION; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; TUMOR GROWTH;

ANIMALS; BETA-LACTAMASES; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, NUDE; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; SIMPLEXVIRUS; SURVIVAL RATE; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0030854392     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am., 271: 58-65, 1994.
2. Lee, C. A., and Falkow, S. The ability of Salmonella to enter mammalian cells is affected by bacterial growth state. Proc. Natl. Acad. Sci. USA, 47: 4304-4308, 1990.
3. Ernst, R. K., Dombroski, D. M., and Merrick, J. M. Anaerobiosis, type 1 fimbriae, and growth phase are factors that affect invasion of HEp-2 cells by Salmonella typhimurium. Infect. Immun., 58: 2014-2016, 1990.
4. Lee, C. A., and Falkow, S. Isolation of hyperinvasive mutants of Salmonella. Methods Enzymol., 236: 531-545, 1994.
5. Bajaj, V., Lucas, R. L., Hwang, C., and Lee, C. A. Coordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol., 22: 703-714, 1996.
6. Bliska, J. B., Galan, J. E., and Falkow, S. Signal transduction in the mammalian cell during bacterial attachment and entry. Cell, 73: 903-920, 1993.
7. Behlau, I., and Miller, S. I. A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J. Bacteriol., 175: 4475-4484, 1993.
8. Tuomanen, E. Subversion of leukocyte adhesion systems by respiratory pathogens. Am. Soc. Microbiol. News, 59: 292-296, 1993.
9. Bermudes, D., and Joiner, K. A. The role of parasites in generating evolutionary novelty. Parasitol. Today, 9: 458-463: 1993.
10. Ginocchio, C. C., Olmsted, S. B., Wells, C. L., and Galán, J. E. Contact with epithelial cells induces the formation of surface appendages on Salmonella typhimurium. Cell, 76: 717-724, 1994.
11. Barinaga, M. A shared strategy for virulence. Science (Washington DC), 272: 1261-1263, 1996.
12. Bacon, G. A., Burrows, T. W., and Yates, M. The effects of biochemical mutation on the virulence of Bacterium typhosum: the loss of virulence of certain mutants. Br. J. Exp. Pathol., 32: 85-96, 1951.
13. Hoiseth, S. K. J., and Stocker, B. A. D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (Lond.), 291: 238-239, 1981.
14. O'Callaghan, D., Maskell, D., Liew, F. Y., Easmon, C. S. F., and Dougan, G. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability induce protective immunity in BALB/c mice. Infect. Immun., 56: 419-423, 1988.
15. Miller, J. H. A Short Course in Bacterial Genetics, pp. 143-156. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1992.
16. Garapin, A. C., Colbere-Garapin, F., Cohen-Solal, M., Horodniceanu, F., and Kourilsky, P. Expression of herpes simplex virus type I thymidine kinase gene in Escherichia coli. Proc. Natl. Acad. Sci. USA, 77: 3369-3373, 1981.
17. McKnight, S. L. The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res., 8: 5949-5964, 1980.
18. Talmadge, K., Stahl, S., and Gilbert, W. Eukaryotic signal sequence transports insulin antigen in Escherchia coli. Proc. Natl. Acad. Sci. USA, 77: 3369-3373, 1980.
19. Weber, K., and Osborn, M. Proteins and sodium dodecyl sulfate: molecular mass determination on polyacrylamide gels and related procedures. In: H. Neurath and R. Hill (eds.), The Proteins, Ed. 3, Vol. I, pp. 179-223, New York: Academic Press, 1975.
20. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
21. Summers, W. C., and Summers, W. P. Deoxydytidine used in a rapid sensitive and specific assay for herpes simples virus type I thymidine kinase. J. Virol., 24: 314-318, 1977.
22. O'Callaghan, D., and Charbit, A. High efficiency transformation of Salmonella typhimurium and Salmonella typhi by electroporation. Mol. Gen. Genet., 223: 156-158, 1990.
23. Randall, L. L., and Hardy, J. S. Correlation of competence for export with lack of tertiary structure of the mature species: a study in vivo of maltose-binding protein in E. coli. Cell, 46: 921-928, 1986.
24. Klein, B. K., Polazzi, J. O., Devine, C. S., Rangwala, S. H., and Olins, P. O. Effects of signal peptide changes on the secretion of bovine somatotropin (bST) from Escherichia coli. Protein Eng., 5: 511-517, 1992.
25. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. (Bethesda), 82: 297-300, 1990.
26. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors. Cancer Res., 53: 83-88, 1993.
27. Blaese, R. M., Ishii-Morita, H., Mullen, C., Ramsey, J., Ram, Z., Oldfield, E., and Culver, K. In situ delivery of suicide genes for cancer treatment. Eur. J. Cancer, 30A: 1193-1201, 1994.
28. Vile, R. G., and Hart, I. R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res., 53: 3860-3864, 1993.
29. Bonnekoh, B., Greenhalgh, D. A., Bundman, D. S., Eckhardt, J. N., Longley, M. A., Chen, S-H., Woo, S. L. C., and Roop, D. R. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J. Invest. Dermatol., 104: 313-317, 1995.
30. Zheng, L. M., Luo, X., Fischer, J., Le, T., Bermudes, D., Low, B., Pawelek, J., and King, I. Attenuated Salmonella typhimurium inhibited tumor metastasis in vivo. Proc. Am. Assoc. Cancer Res., 38: 9, 1997.
31. Nauts, H. C., Swift, W. E., and Coley, B. L. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M. D., reviewed in the light of modern research. Cancer Res., 6: 205-216, 1946.
32. Shear, M. J. Discussion of paper by Reinhard, E. J., Good, J. H. T., and Martin, E. Chemotherapy of malignant neoplastic diseases. J. Am. Med. Assoc., 142: 390, 1950.
33. Carswell, E. A., Old, L. J., Kassel R. L., Green, S., Fiore, N., and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72: 3666-3670, 1975.
34. Berg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNFα-induced death. Science (Washington DC), 274: 782-784, 1996.
35. Zbar, B., Bernstein, I., Tanaka, T., and Rapp, H. J. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovix (strain BCG). Science (Washington DC), 17: 1217-1218, 1970.
36. Axelrod, R. S., Havas, H. F., Murasko, D. M., Bushnell, B., and Guan, C. F. Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignancies. Cancer (Phila.), 61: 2219-2230, 1988.
37. Goonewardene, M. Clinical results and immunologic effects of a mixed bacterial vaccine in cancer patients. Med. Oncol. Tumor Pharmacother., 10: 145-158, 1993.
38. Graham, F. O., and Coleman, P. N. Infection of a secondary carcinoma by Salmonella montevideo. Br. Med. J., 1: 1116, 1952.
39. Giel, C. P. Abscess formation in a pheochromocytoma. N. Engl. J. Med., 251: 980-982, 1954.
40. Gill, G. V., and Holden A. A malignant pleural effusion infected with Salmonella enteritidis. Thorax, 51: 104-105, 1996.
41. Johnson, P. H., and Macfarlane J. T. Commentary. Pleural empyema and malignancy: another direction. Thorax, 51: 107-108, 1996.
42. Parker, R. C., Plummber, H. C., Siebenmann, C. O., and Chapman, M. G. Effect of histolyticus infection and toxin on transplantable mouse tumors. Proc. Soc. Exp. Biol. Med., 66: 461-465, 1947.
43. Rapp, H. J. A guinea pig model for tumor immunology. Israel J. Med. Sci., 9: 366-374, 1973.
44. Schäfer, R., Nacy, C. A., and Eisenstein, T. K. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella. J. Immunol., 140: 1638-1644, 1988.
45. Eisenstein, T. K., Bushnell, B., Meissler, J. J., Jr. Dalal, N., Schafer, R., and Havas, H. F. Immunotherapy of a plasmacytoma with attenuated Salmonella. Med. Oncol. 12: 103-108, 1995.
46. Saltzman, D. A., Heise, C. P., Hasz, D. E., Zebede, M., Kelly, S. M., Curtiss, R., Leonard, A. S., and Anderson P. M. Attenuated Salmonella typhimurium containing interieukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent. Cancer Biother. Radiopharm., 11: 145-153, 1996.
47. Saltzman, D. A., Katsanis, E., Heise, C. P., Hasz, D. E., Kelly, S. M., Curtiss, R., III, Leonard, A. S., and Anderson, P. M. Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interieukin-2: a novel tumor agent. Cancer Biother. Radiopharm., 12: 37-43, 1997.
48. Carrier, M. J., Chatfield, S. N., Dougan, G., Nowicka, U. T. A., O'Callaghan, D., Beesley, J. E., Milano, S., Cillari, E., and Liew, F. Y. Expression of human IL-1β in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. J. Immunol., 148: 1176-1181, 1992.
49. Su, G-F., Brahmbhatt, H. N., deLorenzo, V., Wehland, J., and Timmis, K. N. Extracellular export of shiga toxin B-subunit/haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice. Microb. Pathog., 13: 465-176, 1992.
50. Chabalgoity, J. A., Khan, C. M. A., Nash, A. A., and Hormaeche, C. E. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol., 19: 791-801, 1996.
51. Schafer, R., Portnoy, D. A., Brassell, S. A., and Paterson, Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol., 149: 53-59, 1992.
52. Pan, Z-K. Ikonomidis, G., Lazenby, A., Pardoll, D., and Paterson, Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat. Med., 1: 471-477, 1995.
53. Sizemore, D. R., Branstrom, A. A., and Sadoff, J. C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science (Washington DC), 270: 299-302, 1995.
54. Fox, M. E., Lemmon, M. J., Mauchline, M. L., Davis, T. O., Giaccia, A. J., Minton, N. P., and Brown, J. M. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther., 3: 173-178, 1996.
55. Minton, N. P., Mauchline, M. L., Lemmon, M. J., Brehm, J. K., Fox, M., Michael, N. P., Giaccia A., and Brown, J. M. Chemotherapeutic tumor targeting using clostridial spores. FEMS Microbiol. Rev., 17: 357-364, 1995.
56. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M. W., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C-I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2: 985-991, 1996.
57. Arends, M. J., and Wyllie, A. H. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol., 32: 223-254, 1991.